Home/Pipeline/TEECAD

TEECAD

Visualization for transesophageal echocardiogram (TEE) probe placement

ApprovedActive

Key Facts

Indication
Visualization for transesophageal echocardiogram (TEE) probe placement
Phase
Approved
Status
Active
Company

About Visura Technologies

Visura Technologies is a private, commercial-stage medical device company based in San Francisco, founded in 2018. The company has successfully developed and gained FDA clearance for TEECAD, a novel disposable camera system designed to enhance the safety and efficiency of TEE probe placement, a common but blind procedure in cardiology and critical care. By providing direct visualization, Visura aims to reduce complications associated with esophageal intubation, such as trauma and perforation. The company is positioned in the high-growth intersection of the diagnostics and digital health sectors, with a clear path to market through its first commercial product.

View full company profile

Therapeutic Areas